Sanofi (SNYNF)

PNK: SNYNF · Real-Time Price · USD

111.61

0.61 (0.55%)

At close: May 01, 2025, 1:01 PM

Sanofi Balance Sheet Statement

Financials in EUR. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	7.44B	8.71B	12.74B	10.1B	13.91B	9.43B	6.92B	10.31B	10.27B
Short-Term Investments	486M	270M	664M	1.05B	900M	426M	199M	77M	31M
Long-Term Investments	3.26B	2.67B	9.15B	7.97B	7.15B	11.69B	10.99B	10.52B	10.38B
Other Long-Term Assets	1.37B	13.63B	-5.14B	-4.42B	-3.96B	-5.43B	-4.61B	-4.29B	-4.67B
Receivables	10.63B	11.04B	10.75B	9.79B	7.49B	10.08B	9.35B	8.68B	9.05B
Inventory	9.43B	9.67B	20.92B	19.85B	18.58B	19.18B	17.65B	16.04B	16.41B
Other Current Assets	13.71B	216M	291M	384M	384M	513M	232M	167M	6.53B
Total Current Assets	42.59B	30.67B	34.11B	30.65B	33.79B	28.94B	24.65B	26.39B	33.11B
Property-Plant & Equipment	11.6B	11.81B	11.68B	11.98B	10.56B	11.02B	9.65B	9.58B	10.02B
Goodwill & Intangibles	66.01B	67.69B	69.39B	69.46B	62.78B	61.09B	66.12B	53.34B	51.17B
Total Long-Term Assets	90.21B	95.79B	90.47B	89.59B	80.74B	83.8B	86.76B	73.44B	71.56B
Total Assets	132.8B	126.46B	124.58B	120.24B	114.53B	112.74B	111.41B	99.83B	104.67B
Account Payables	7.55B	7.33B	6.81B	6.18B	6.18B	5.31B	5.04B	4.63B	4.3B
Deferred Revenue	n/a	n/a	264M	319M	822M	n/a	n/a	n/a	n/a
Short-Term Debt	4.21B	2.04B	4.17B	3.18B	3.18B	4.55B	2.63B	1.27B	1.76B
Other Current Liabilities	15.13B	12.62B	10.73B	10.05B	8.03B	9.23B	8.42B	7.98B	9.98B
Total Current Liabilities	29.16B	24.21B	23.97B	21.3B	19.28B	20.39B	17.38B	15.46B	17.63B
Long-Term Debt	11.79B	14.35B	14.86B	17.12B	17.12B	20.13B	22.01B	14.33B	16.82B
Other Long-Term Liabilities	10.18B	11.8B	2.02B	2.19B	11.52B	2.8B	4.38B	2.63B	3.67B
Total Long-Term Liabilities	25.78B	27.9B	27.1B	29.92B	32.1B	33.24B	35B	26.11B	29.32B
Total Liabilities	54.94B	52.11B	51.07B	51.21B	51.38B	53.63B	52.37B	41.57B	46.95B
Total Debt	17.91B	18.42B	21.21B	22.41B	23.68B	25.93B	24.64B	15.6B	18.58B
Common Stock	2.53B	2.53B	2.52B	2.53B	2.52B	2.51B	2.5B	2.51B	2.58B
Retained Earnings	n/a	n/a	66.73B	63.01B	60.15B	51.78B	53.11B	52.86B	51.48B
Comprehensive Income	70.56B	67.44B	68.19B	62.16B	56.69B	52.57B	52.94B	52.3B	53.44B
Shareholders Equity	77.51B	74.04B	73.14B	68.68B	63B	58.93B	58.88B	58.09B	57.55B
Total Investments	3.75B	2.94B	9.82B	9.03B	8.05B	12.12B	11.19B	10.59B	10.41B